These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 24777159)

  • 41. Corticosteroid-induced myopathy in spinal cord injury patients: a role for anticatabolic agents?
    Dickerman RD; Joseph AM; Bennett MT
    Spinal Cord; 2006 Apr; 44(4):263-4. PubMed ID: 16172629
    [No Abstract]   [Full Text] [Related]  

  • 42. Methylprednisolone after spinal cord injury.
    Segatore M; Way C
    SCI Nurs; 1993 Mar; 10(1):8-14. PubMed ID: 8484108
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacological therapy after acute cervical spinal cord injury.
    Hadley MN; Walters BC; Grabb PA; Oyesiku NM; Przybylski GJ; Resnick DK; Ryken TC
    Neurosurgery; 2002 Mar; 50(3 Suppl):S63-72. PubMed ID: 12431289
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Steroids after spinal cord injury.
    Lancet; 1990 Aug; 336(8710):279-80. PubMed ID: 1973973
    [No Abstract]   [Full Text] [Related]  

  • 45. Spinal cord injuries in older children: is there a role for high-dose methylprednisolone?
    Arora B; Suresh S
    Pediatr Emerg Care; 2011 Dec; 27(12):1192-4. PubMed ID: 22158284
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial.
    Bracken MB; Shepard MJ; Holford TR; Leo-Summers L; Aldrich EF; Fazl M; Fehlings MG; Herr DL; Hitchon PW; Marshall LF; Nockels RP; Pascale V; Perot PL; Piepmeier J; Sonntag VK; Wagner F; Wilberger JE; Winn HR; Young W
    J Neurosurg; 1998 Nov; 89(5):699-706. PubMed ID: 9817404
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-dose methylprednisolone may cause myopathy in acute spinal cord injury patients.
    Qian T; Guo X; Levi AD; Vanni S; Shebert RT; Sipski ML
    Spinal Cord; 2005 Apr; 43(4):199-203. PubMed ID: 15534623
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacologic Management of Acute Spinal Cord Injury.
    Karsy M; Hawryluk G
    Neurosurg Clin N Am; 2017 Jan; 28(1):49-62. PubMed ID: 27886882
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Easing the trauma. Finally, a way to limit damage from spinal injuries.
    Rusting R
    Sci Am; 1990 Jun; 262(6):34, 36-7. PubMed ID: 2343292
    [No Abstract]   [Full Text] [Related]  

  • 50. The use of methylprednisolone.
    Bracken MB
    J Neurosurg; 2000 Oct; 93(2 Suppl):340-1. PubMed ID: 11012076
    [No Abstract]   [Full Text] [Related]  

  • 51. Changes in the use of the methylprednisolone protocol for traumatic spinal cord injury in Switzerland.
    Felleiter P; Müller N; Schumann F; Felix O; Lierz P
    Spine (Phila Pa 1976); 2012 May; 37(11):953-6. PubMed ID: 22020592
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of methylprednisolone in acute spinal cord injury.
    Bracken MB; Collins WF; Freeman DF; Shepard MJ; Wagner FW; Silten RM; Hellenbrand KG; Ransohoff J; Hunt WE; Perot PL
    JAMA; 1984 Jan; 251(1):45-52. PubMed ID: 6361287
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of steroids for acute spinal cord injury must be reassessed.
    Short D
    BMJ; 2000 Nov; 321(7270):1224. PubMed ID: 11073527
    [No Abstract]   [Full Text] [Related]  

  • 54. Promising pharmacological agents in the management of acute spinal cord injury.
    Seidl EC
    Pharm Pract Manag Q; 2000 Apr; 20(1):21-7. PubMed ID: 10947539
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Expression of neurotrophin and IL-1 beta mRNAs following spinal cord injury and the effects of methylprednisolone treatment].
    Hayashi M; Ueyama T; Tamaki T; Senba E
    Kaibogaku Zasshi; 1997 Jun; 72(3):209-13. PubMed ID: 9251297
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug incompatibility with methylprednisolone.
    Mehta M
    J Neurosurg Anesthesiol; 2008 Jul; 20(3):209-10. PubMed ID: 18580356
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparison of the Effects of Methotrexate and Methylprednisolone in Spinal Cord Injury in Rats.
    Meng H; Liu Y; Li K; Li J
    Drug Res (Stuttg); 2015 Aug; 65(8):437-41. PubMed ID: 25333652
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased susceptibility of patients with cervical cord lesions to peptic gastrointestinal complications.
    Soderstrom CA; Ducker TB
    J Trauma; 1985 Nov; 25(11):1030-8. PubMed ID: 3877174
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Therapeutic time window for methylprednisolone in spinal cord injured rat.
    Yoon DH; Kim YS; Young W
    Yonsei Med J; 1999 Aug; 40(4):313-20. PubMed ID: 10487132
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Magnesium efficacy in a rat spinal cord injury model.
    Wiseman DB; Dailey AT; Lundin D; Zhou J; Lipson A; Falicov A; Shaffrey CI
    J Neurosurg Spine; 2009 Apr; 10(4):308-14. PubMed ID: 19441987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.